Robert Carnahan, PhD, and Seth Zost, PhD, from the Vanderbilt University Medical Center, describe how they have used the Beacon platform, to rapidly discover hundreds of unique antibodies against SARS-CoV-2.

Please fill out the following form to access this resource:

First Name*
Last Name*
Email Address*
Phone Number*
City*
Country*
State*
Company/Institute*
CAPTCHA

Related Resources

View All Resources

Antibody Discovery

Application Note: Accessing Greater Antibody Sequence Diversity

See how you can discover >5,000 antigen-specific hits from a single plasma B cell sample and recover >650 unique BCR sequences in under 1 week.

Antibody Discovery

Poster: Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2

Find out how B Cell Antibody Discovery on the Beacon system can be used to rapidly screen human B cell to discover antibodies against difficult targets such as viruses.

Antibody Discovery

Webinar: Antibody Engineering & Therapeutics Digital Week 2019

Learn about accelerating target-to-lead antibody candidate selection with the Beacon platform in this Antibody Engineering & Therapeutics Digital Week 2019 webinar.